Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Hepatobiliary Pancreat Sci ; 28(4): 327-335, 2021 Apr.
Article in English | MEDLINE | ID: mdl-32359017

ABSTRACT

BACKGROUND/PURPOSE: Few clinically useful biomarkers are known to predict prognosis in patients with hepatocellular carcinoma (HCC). The aim of this study was to investigate the correlation between PPAR activity and ALDH7A1 expression and their prognostic significance using RNA sequencing in patients undergoing liver resection for HCC. METHODS: We included patients undergoing liver resection for HCC at a tertiary referral center for hepato-pancreato-biliary surgery between May 2014 and January 2018. PPAR activity and ALDH7A1 expression were evaluated by RNA sequencing and correlated with overall survival, recurrence and histological features. RESULTS: We included 52 patients with a median follow-up of 20.9 months, predominantly males (88.5%) with a single tumor (84.6%) in a non-cirrhotic liver (73.1%). Three-year overall survival was 48.6% in patients with a specific PPAR target gene expression profile (cancer cluster 3) compared with 81.7% in controls (P = .04, Log-rank test). This remained significant (odds ratio 14.02, 95% confidence interval 1.92-102.22, P = .009) when adjusted for age, cirrhosis, microvascular invasion, number of tumors and free resection margins. ALDH7A1 expression was not correlated with PPAR or any outcomes. CONCLUSION: PPAR activity in a subset of tumor samples was associated with reduced overall survival indicating that PPAR may be a valuable prognostic biomarker.


Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , Peroxisome Proliferator-Activated Receptors , Carcinoma, Hepatocellular/surgery , Disease-Free Survival , Female , Hepatectomy , Humans , Liver Neoplasms/surgery , Male , Neoplasm Recurrence, Local/surgery , Peroxisome Proliferator-Activated Receptors/genetics , Prognosis , Retrospective Studies
2.
G3 (Bethesda) ; 10(4): 1319-1325, 2020 04 09.
Article in English | MEDLINE | ID: mdl-32111652

ABSTRACT

The Hippo pathway regulates growth and apoptosis. We identify RhoBTB proteins as novel regulators of Hippo signaling. RhoBTB depletion in the Drosophila wing disc epithelium cooperated with Yki to drive hyperplasia into neoplasia. Depletion of RhoBTB2 caused elevated YAP activity in human cells. RhoBTB2 deficiency resulted in increased colony formation in assays for anchorage-independent growth. We provide evidence that RhoBTBs acts on Hippo signaling through regulation of the kinase LKB1. LKB1 protein levels were reduced upon RhoBTB2 depletion, which correlated with increased LKB1 ubiquitination. Restoring LKB1 levels rescued loss of RhoBTB in Drosophila Our results suggest that RhoBTB-dependent LKB1 regulation may contribute to its tumor-suppressive function.


Subject(s)
Drosophila Proteins , Protein Serine-Threonine Kinases , Signal Transduction , AMP-Activated Protein Kinase Kinases , Animals , Drosophila Proteins/genetics , Drosophila Proteins/metabolism , Drosophila melanogaster/genetics , Drosophila melanogaster/metabolism , GTP-Binding Proteins , Hippo Signaling Pathway , Humans , Intracellular Signaling Peptides and Proteins , Nuclear Proteins/genetics , Protein Kinases , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Trans-Activators/metabolism , Ubiquitination
3.
Gland Surg ; 8(4): 327-328, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31538055
SELECTION OF CITATIONS
SEARCH DETAIL
...